Latest Breaking News On - Shuttle pharmaceuticals - Page 1 : comparemela.com

SHPH Stock Earnings: Shuttle Pharmaceuticals Reported Results for Q1 2024

SHPH Stock Earnings: Shuttle Pharmaceuticals Reported Results for Q1 2024
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

Shuttle pharmaceuticalsPlace earnings

Histone Deacetylase 6 Drug Pipeline Research Report 2024:

Dublin, April 12, 2024 (GLOBE NEWSWIRE) The

Regenacy pharmaceuticalsricolinostatHillstream biopharmaKarus therapeuticsChong kun dang pharmaceuticalsChong kun dangPipeline development activitiesCelgene corporationCstone pharmaceuticalsRegenacy pharmaceuticalsShuttle pharmaceuticalsRoute of administrationKey companiesHistone deacetylaseEmerging drugsEvaluate efficacyTreatment combination

Rockville s Shuttle Diagnostics to pursue $4 5M rights offering

Rockville s Shuttle Diagnostics to pursue $4 5M rights offering
thedailyrecord.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thedailyrecord.com Daily Mail and Mail on Sunday newspapers.

United statesShuttle diagnostics incBoustead securitiesShuttle pharmaceuticalsGeorgetown universityShuttle pharmaceuticals holdings incPharmaceuticals holdings incRockville based shuttle diagnostics incMedical center

Shuttle Pharma to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024

/PRNewswire/ Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on improving.

Robert blumAnatoly dritschiloLytham partnersGeorgetown universityShuttle pharmaceuticalsPrnewswire shuttle pharmaceuticals holdings incCompany webcastShuttle pharmaceuticals holdings incPharmaceuticals holdingsChief executive officerSelect conferenceMedical centerShuttle pharmaceuticals holdings

Shuttle Pharma to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024

ROCKVILLE, Md., Jan. 23, 2024 /PRNewswire/ Shuttle Pharmaceuticals Holdings, Inc. , a discovery and development stage specialty pharmaceutical company focused on improving the outcomes of cancer.

Robert blumAnatoly dritschiloGeorgetown universityShuttle pharmaceuticalsPrnewswire shuttle pharmaceuticals holdings incCompany webcastLytham partnersShuttle pharmaceuticals holdings incPharmaceuticals holdingsChief executive officerSelect conferenceMedical center